>my guess is that Macugen / Visudyne / steroids together make up about 10% of new RX, so avastin is still getting 35%. from that calculation, I would guess that number is more like 40% for existing rxs for avastin.<
I think your estimates are on target.
“The efficient-market hypothesis may be the foremost piece of B.S. ever promulgated in any area of human knowledge!”